Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 40 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 60 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 80 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 20 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - alfacalcidol - capsule, liquid filled - 0.5 mcg - alfacalcidol 0.5 mcg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - alfacalcidol - capsule, liquid filled - 0.25 mcg - alfacalcidol 0.25 mcg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - celecoxib, quantity: 200 mg - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate; sodium lauryl sulfate; povidone; gelatin; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol; strong ammonia solution; potassium hydroxide; iron oxide black - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - celecoxib, quantity: 200 mg - capsule, hard - excipient ingredients: povidone; sodium lauryl sulfate; gelatin; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; croscarmellose sodium; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - celecoxib, quantity: 100 mg - capsule, hard - excipient ingredients: gelatin; povidone; titanium dioxide; colloidal anhydrous silica; lactose monohydrate; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - celecoxib, quantity: 100 mg - capsule, hard - excipient ingredients: croscarmellose sodium; gelatin; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; povidone; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.